Guardant Health
GH
$16.07
Share price
-3.60%
Change (1 day)
-35.15%
Change (1 year)
Categories
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.
Guardant Health (GH) Fails to deliver data
Key failure to deliver metrics for Guardant Health :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.04 M
- Last 3 months FTD volume: $0.29 M
- Last year FTD volume: $10.34 M
Failures to deliver for Guardant Health (GH) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Guardant Health (GH) - since 2018
Volume in USD (price x number of shares), data since 2018Guardant Health (GH) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.29 M | -97.92% |
| 2023 | $14.08 M | 47.94% |
| 2022 | $9.51 M | -97.95% |
| 2021 | $0.46 B | 195% |
| 2020 | $0.15 B | -29.91% |
| 2019 | $0.22 B | 2130.55% |
| 2018 | $10.06 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Neogen NEOG | $14.03 M | $16.14 M | 🇺🇸 USA |
 Natera NTRA | $2.23 M | $22.04 M | 🇺🇸 USA |